Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02459301
Title Dose-Ranging Study of IPH2201 in Patients With High Grade Serious CA of Ovarian, Fallopian Tube or Peritoneal Origin
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
BCCA - Cancer Centre for the Southern Interior Kelowna British Columbia V1Y 5L3 Canada Details
BCCA - Vancouver Cancer Centre Vancouver British Columbia V5Z 4E6 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences Hamilton Ontario L8V 5C2 Canada Details
London Regional Cancer Program London Ontario N6A 5W9 Canada Details
University Health Network Toronto Ontario M5G 2M9 Canada Details
CHUM - Hopital Notre-Dame Montreal Quebec H2L 4M1 Canada Details
*Shaded cells indicate that there was no data available from for the field